Before attributing COVID_19-related ischemic stroke to hypercoagulability alternative causes should be excluded.
作者信息
Elkhider Hisham, Ibrahim Faisal, Onteddu Sanjeeva, Nalleballe Krishna
机构信息
Department of Neurology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Department of Neurology, Southern Illinois University, Springfield, IL, USA.
出版信息
Brain Behav Immun Health. 2021 Feb;11:100179. doi: 10.1016/j.bbih.2020.100179. Epub 2020 Dec 3.
Abstract
摘要
相似文献
1
Before attributing COVID_19-related ischemic stroke to hypercoagulability alternative causes should be excluded.在将与COVID-19相关的缺血性中风归因于高凝状态之前，应排除其他可能原因。
Brain Behav Immun Health. 2021 Feb;11:100179. doi: 10.1016/j.bbih.2020.100179. Epub 2020 Dec 3.
2
Before attributing COVID_19-related ischemic stroke to hypercoagulability alternative causes should be excluded.在将COVID-19相关的缺血性中风归因于高凝状态之前，应排除其他可能的原因。
Brain Behav Immun Health. 2021 Jan;10:100178. doi: 10.1016/j.bbih.2020.100178. Epub 2020 Nov 27.
3
SARS-CoV-2 and Stroke in a New York Healthcare System.SARS-CoV-2 与纽约医疗体系中的中风。
Stroke. 2020 Jul;51(7):2002-2011. doi: 10.1161/STROKEAHA.120.030335. Epub 2020 May 20.
4
Stroke epidemiology and COVID-19 pandemic.卒中流行病学与 COVID-19 大流行。
Curr Opin Neurol. 2021 Feb 1;34(1):3-10. doi: 10.1097/WCO.0000000000000879.
5
Hypercoagulability and Mortality of Patients with Stroke and Active Cancer: The OASIS-CANCER Study.中风与活动性癌症患者的高凝状态及死亡率：OASIS-癌症研究
J Stroke. 2017 Jan;19(1):77-87. doi: 10.5853/jos.2016.00570. Epub 2016 Dec 12.
6
Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings.COVID-19 感染患者的恶性大脑缺血：病例回顾与组织病理学发现。
J Stroke Cerebrovasc Dis. 2020 Nov;29(11):105231. doi: 10.1016/j.jstrokecerebrovasdis.2020.105231. Epub 2020 Aug 5.
7
Unfractionated Heparin in SARS-CoV-2 Pneumonia: Ischemic Stroke Case Report.未分级肝素用于新型冠状病毒肺炎：缺血性中风病例报告
Front Neurol. 2020 Sep 25;11:573356. doi: 10.3389/fneur.2020.573356. eCollection 2020.
8
Coronavirus Disease 2019-Related Acute Ischemic Stroke: A Case Report.2019年冠状病毒病相关急性缺血性卒中：一例报告
Cureus. 2020 Sep 8;12(9):e10310. doi: 10.7759/cureus.10310.
9
Homocysteine-lowering treatment with folic acid, cobalamin, and pyridoxine does not reduce blood markers of inflammation, endothelial dysfunction, or hypercoagulability in patients with previous transient ischemic attack or stroke: a randomized substudy of the VITATOPS trial.对于既往有短暂性脑缺血发作或中风的患者，使用叶酸、钴胺素和吡哆醇进行降低同型半胱氨酸治疗，并不会降低炎症、内皮功能障碍或高凝状态的血液标志物：VITATOPS试验的一项随机子研究。
Stroke. 2005 Jan;36(1):144-6. doi: 10.1161/01.STR.0000150494.91762.70. Epub 2004 Nov 29.
10
Value of prothrombin fragment 1.2 (F 1.2) in the diagnosis of stroke in young patients with antiphospholipid antibodies.
Clin Appl Thromb Hemost. 2000 Apr;6(2):61-4. doi: 10.1177/107602960000600201.
本文引用的文献
1
Encephalopathy in COVID-19 patients; viral, parainfectious, or both?新冠病毒感染患者的脑病：病毒感染、感染后状态，还是两者皆有？
eNeurologicalSci. 2020 Dec;21:100275. doi: 10.1016/j.ensci.2020.100275. Epub 2020 Sep 21.
2
Acute encephalopathy is associated with worse outcomes in COVID-19 patients.急性脑病与新冠病毒感染患者更差的预后相关。
Brain Behav Immun Health. 2020 Oct;8:100136. doi: 10.1016/j.bbih.2020.100136. Epub 2020 Sep 1.
3
Falling stroke rates during COVID-19 pandemic at a comprehensive stroke center.在综合性卒中中心，COVID-19 大流行期间卒中发生率下降。
J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104953. doi: 10.1016/j.jstrokecerebrovasdis.2020.104953. Epub 2020 May 14.
4
Underutilization of health care for strokes during the COVID-19 outbreak.2019冠状病毒病疫情期间中风医疗服务利用不足。
Int J Stroke. 2020 Jul;15(5):NP9-NP10. doi: 10.1177/1747493020934362. Epub 2020 Jun 18.
5
COVID-19 presenting as stroke.COVID-19 以中风为表现形式。
Brain Behav Immun. 2020 Jul;87:115-119. doi: 10.1016/j.bbi.2020.04.077. Epub 2020 Apr 28.
Zotero 插件